Homocysteine
High Density Lipoprotein Cholesterol
Low Density Lipoprotein Cholesterol
Lipoprotein (a)
Non-esterified Fatty Acids
| Abbr. | Description | Method | Package Size |
|---|---|---|---|
| HCY | Homocysteine |
Enzymatic Cycling MethodDouble reagent
|
|
| Lp-PLA2 | Lipoprotein-associated Phospholipase A2 |
Continuous Monitoring Method
|
|
| Lipid Control | Lipid Control |
Lyopholized
|
|
| PL | Phospholipid |
Peroxidase MethodDouble reagent
|
|
| ApoA1 | Apolipoprotein A1 |
Immunoturbidimetric MethodDouble reagent
|
|
| ApoB | Apolipoprotein B |
Immunoturbidimetric MethodDouble reagent
|
|
| Apo E | Apolipoprotein E |
Immunoturbidimetric MethodDouble reagent
|
|
| APOAⅡ | Apolipoprotein AⅡ |
Immunoturbidimetric MethodDouble reagent
|
|
| ApoCⅢ | Apolipoprotein C Ⅲ |
Immunoturbidimetric MethodDouble reagent
|
|
| CHO | Cholesterol |
CHOD-PAP MethodSingle reagent
|
|
| HDL-C | High Density Lipoprotein Cholesterol |
Direct Method - Select Inhibition MethodDouble reagent
|
|
| LDL-C | Low Density Lipoprotein Cholesterol |
Direct Method - Surfactant Clearance MethodDouble reagent
|
|
| Lp(a) | Lipoprotein (a) |
Immunoturbidimetric MethodDouble reagent
|
|
| NEFA | Non-esterified Fatty Acids |
ACS-ACOD MethodDouble reagent
|
|
| TG | Triglyceride |
GPO-PAP MethodSingle reagent
|
|